Form 8-K - Current report:
SEC Accession No. 0000950170-22-000245
Filing Date
2022-01-12
Accepted
2022-01-12 07:17:10
Documents
15
Period of Report
2022-01-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dna-20220112.htm   iXBRL 8-K 64178
2 EX-99.1 dna-ex99_1.htm EX-99.1 25315
3 GRAPHIC img197909486_0.jpg GRAPHIC 4122
  Complete submission text file 0000950170-22-000245.txt   268990

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dna-20220112.xsd EX-101.SCH 3399
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dna-20220112_pre.xml EX-101.PRE 15337
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dna-20220112_def.xml EX-101.DEF 15106
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dna-20220112_lab.xml EX-101.LAB 24109
9 EXTRACTED XBRL INSTANCE DOCUMENT dna-20220112_htm.xml XML 6558
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Filer) CIK: 0001830214 (see all company filings)

EIN.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40097 | Film No.: 22525575
SIC: 2836 Biological Products, (No Diagnostic Substances)